Patients who received the Tecnis PureSee extended depth of focus IOL had a high tolerance to residual refractive error, ...
Patients with bilateral limbal cell deficiency or previous failed keratoplasty may be candidates for KPro, according to a ...
Semaglutide use was not tied to a higher risk for non-arteritic anterior ischemic optic neuropathy, or NAION, in patients ...
Non-FDA-approved GLP-1 receptor agonists remain largely available despite recent resolutions to drug shortages, data at the ...
Alcon launched its Clareon TruPlus enhanced monofocal and toric IOLs in the U.S., according to a press release.The lens ...
Structured de-escalation of GLP-1 receptor agonists may lead to sustained health benefits while reducing treatment burden, ...
When preparing for cataract surgery in patients with retinal pathologies, ophthalmologists must be sure to set reasonable ...
The best candidates for corneal tissue addition keratoplasty fit certain topographical and visual criteria, according to a ...
An at-home program with live movement- and meditation-based classes started in response to the COVID-19 pandemic has not only ...
Adults with type 2 diabetes and overweight or obesity who use a GLP-1 receptor agonist have similar risk for kidney cancer as ...
The direction of the risk for Alzheimer’s disease and related dementias differed based on the quality of a plant-based diet, ...
Please provide your email address to receive an email when new articles are posted on . The update allows for treatment beyond 6 months. Vabysmo was approved to treat macular edema following RVO in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results